Sutro biopharma stock
Web11 apr 2024 · Sutro Biopharma is playing second fiddle to perpetually second fiddle player ImmunoGen in ovarian cancer. Click here to read my latest analysis of STRO stock. Web5 apr 2024 · By Sarah Baker. April 5, 2024. For the readers interested in the stock health of Sutro Biopharma Inc. (STRO). It is currently valued at $4.31. When the transactions were called off in the previous session, Stock hit the highs of $4.805, after setting-off with the price of $4.71. Company’s stock value dipped to $4.245 during the trading on the ...
Sutro biopharma stock
Did you know?
Web102 righe · 31 mar 2024 · Sutro Biopharma, Inc. (STRO) NasdaqGM - NasdaqGM Real … Web31 mar 2024 · Stay up to date on Sutro Biopharma analyst ratings. If you are interested in following small-cap stock news and performance you can start by tracking it here.
Web10 feb 2024 · You can click the graphic below for the historical numbers, but it shows that Sutro Biopharma had US$19.3m of debt in September 2024, down from US$25.0m, one year before. But it also has US$324.2m in cash to offset that, meaning it has US$305.0m net cash. NasdaqGM:STRO Debt to Equity History February 10th 2024. Web15 giu 2024 · Sutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57M Seeking Alpha 10d Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates
Web10 apr 2024 · Comparatively, Sutro Biopharma has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Insider & Institutional Ownership 99.5% of Coherus BioSciences shares are ... Web1 mar 2024 · Sutro Biopharma, Inc., headquartered in South San Francisco, is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). Sutro has two wholly owned ADCs in the clinic—STRO-002, a folate receptor alpha (FolRα)-targeting ADC, in clinical studies for ovarian and endometrial cancers; and …
WebSutro Biopharma, Inc. (STRO) Stock Price, News, Quote & History - Yahoo Finance Sutro Biopharma, Inc. (STRO) NasdaqGM - NasdaqGM Real Time Price. Currency in USD …
Web23 ore fa · Analysts` Top Healthcare Picks: Sutro Biopharma (STRO), ATAI Life Sciences (ATAI) 03/31/23-7:31AM EST TipRanks Sutro Biopharma price target lowered to $16 from $20 at H.C. Wainwright granylosyytti tarkoittaaWebSutro Biopharma. 111 Oyster Point Blvd South San Francisco, CA 94080 Phone: 650-881-6500 Fax: 650-553-9659. Google Map gra online pistoletyWebSutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on … grapevine jointerWeb30 mar 2024 · - As of year-end 2024, Sutro had cash and investments of $302.3 million and shares of Vaxcyte common stock valued at $32.0 million, which together provide a projected cash runway into the second half of 2024-. SOUTH SAN FRANCISCO, Calif., March 30, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the … granvista hotelmarcelo hotelmakin hotelWeb29 mar 2024 · Sutro Biopharma. stock was originally listed at a price of $15.20 in Sep 27, 2024. If you had invested in Sutro Biopharma stock at $15.20, your return over the last 4 years would have been -68.62%, for an annualized return of -25.15% (not including any dividends or dividend reinvestments). grape kombi lasten polkupyörä mustaWeb6 apr 2024 · According to analysts, Sutro Biopharma's stock has a predicted upside of 200.22% based on their 12-month price targets. What analysts cover Sutro Biopharma? … granyte rain jacketWebThe Sutro Biopharma stock prediction for 2025 is currently $ 4.66, assuming that Sutro Biopharma shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -2.37% increase in the STRO stock price. Sutro Biopharma Stock Prediction 2030. gran vista toa alta